Published in Medical Letter on the CDC and FDA, February 4th, 2007
The company anticipates initiating a Phase I clinical study of trodusquemine in the first half of 2007.
As a result of this strategic decision, Genaera will reduce its workforce by approximately...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.